BiotechTube
Home/AvenCell Therapeutics/Manfred Klevesath, MD, Ph.D.
MK

Manfred Klevesath, MD, Ph.D.

Chief Medical Officer

AvenCell Therapeutics

Therapeutic Areas

Oncology

AvenCell Therapeutics Pipeline

DrugIndicationPhase
Universal Switchable CAR-T ProgramsHard-to-treat cancers (hematological and solid tumors)Phase 1

Leadership Team at AvenCell Therapeutics

AS
Andrew Schiermeier, Ph.D.
Chief Executive Officer
RL
Reynald Lescarbeau, Ph.D.
SVP, Global Research
MC
Marc Cartellieri, Ph.D.
Chief Technology Officer
SB
Susan Buttler
VP, Clinical Operations
View full AvenCell Therapeutics profile